I

I-MAB
D

IMAB

1.07000
USD
0.00
(0.00%)
مفتوح الان
حجم التداول
1,100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
87,206,163
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: I/MAB

القطاع: Healthcare
الصناعة: Biotechnology
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).